For over 30 years Dr. Clay Siegall has been working to help develop better, more effective treatments for cancer. His interest in fighting the disease began when he was 19 years old and saw his father being ravished by the disease. Since that time he has worked with some of the leading companies involved in cancer research and has had his share of victories. In 1998, he co-founded Seattle Genetics. In the almost 20 years since, the company has made major breakthroughs and has developed some of the most effective cancer treatment drugs in the world today. But Dr. Siegall isn’t done yet.
Although Dr. Clay Siegal has received numerous awards for his work as an entrepreneur and scientist, he is not yet satisfied. Fighting cancer is his passion. He has written extensively on the subject and collaborated with leading oncologists, innovators and companies to develop and distribute viable treatments. But he has had his most spectacular success through the work at Seattle Genetics. The company is famous for developing ADCETRIS, the first antibody-drug conjugate to receive approval from the FDA. ADCETRIS is now used to help people suffering with cancer all over the world.
Part of the work Dr. Siegall does at Seattle Genetics is fundraising. The research and development activities in which the company engages is very expensive. It requires highly-trained, experienced professionals and technologies which have a high price. To keep the development pipeline going, Dr. Siegall has raised in excess of $1.2 billion dollars. He’s done so through a successful IPO, reaching out to public and private sources and creating licensing partnerships with companies wanting to market ADCETRIS to oncologists and cancer patients worldwide.
Through the work and leadership of Dr. Clay Siegall, Seattle Genetics has a development pipeline with dozens of viable cancer treatments poised to be shared with cancer patients. But he’s also learned even with his degrees and experience, the key to his success is his interactions with smart people. They have the knowledge and expertise to solve the problems cancer presents. With their support he’s been able to improve life for many.